{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T02:36:31Z","timestamp":1764815791401},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,6]]},"DOI":"10.7759\/cureus.11935","type":"journal-article","created":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T17:21:16Z","timestamp":1607275276000},"source":"Crossref","is-referenced-by-count":2,"title":["Pregabalin-Induced Myopathy in a Double Lung Transplant Recipient"],"prefix":"10.7759","author":[{"given":"Vishwajit","family":"Hegde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Shekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Baz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Anstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.01.013","article-title":"Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders","volume":"29","author":"Tassone DM","year":"2007","unstructured":"Tassone DM, Boyce E, Guyer J, Nuzum D. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. ClinTher. 2007, 29:26-48. 10.1016\/j.clinthera.2007.01.013","journal-title":"ClinTher"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2010.06625.x","article-title":"Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate","volume":"113","author":"Kumar N","year":"2010","unstructured":"Kumar N, Laferriere A, Yu JS, Leavitt A, Coderre TJ. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem. 2010, 113:552-561. 10.1111\/j.1471-4159.2010.06625.x","journal-title":"J Neurochem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2042098613505614","article-title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","volume":"5","author":"Toth C","year":"2014","unstructured":"Toth C. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf. 2014, 5:38-56. 10.1177\/2042098613505614","journal-title":"Ther Adv Drug Saf"},{"key":"ref4","article-title":"Pregabalin and simvastatin: first report of a case of rhabdomyolysis","volume":"37","author":"Kaufman MB","year":"2012","unstructured":"Kaufman MB, Choy M. Pregabalin and simvastatin: first report of a case of rhabdomyolysis. P&T. 2012, 37:579-95.","journal-title":"P&T"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5694\/mja13.10769","article-title":"Pregabalin-associated rhabdomyolysis","volume":"199","author":"Gunathilake R","year":"2013","unstructured":"Gunathilake R, Boyce LE, Knight AT. Pregabalin-associated rhabdomyolysis. Med J Aust. 2013, 199:624-625. 10.5694\/mja13.10769","journal-title":"Med J Aust"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evo KE","year":"2017","unstructured":"Evo KE, Morrison MD, Saklad SR. Abuse and misuse of pregabalin and gabapentin. Drugs. 2017, 77:403-426. 10.1007\/s40265-017-0700-x","journal-title":"Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-010-0104-3","article-title":"Drug-related myopathies of which the clinician should be aware","volume":"12","author":"Valiyil R","year":"2010","unstructured":"Valiyil R, Christopher-Stine L. Drug-related myopathies of which the clinician should be aware. Curr Rheumatol Rep. 2010, 12:213-220. 10.1007\/s11926-010-0104-3","journal-title":"Curr Rheumatol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(78)92894-5","article-title":"Drug-induced myopathies in man","volume":"312","author":"Lane RJ","year":"1978","unstructured":"Lane RJ, Mastaglia FL. Drug-induced myopathies in man. Lancet. 1978, 312:562-566. 10.1016\/s0140-6736(78)92894-5","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2018.07.022","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation","volume":"37","author":"Khush KK","year":"2018","unstructured":"Khush KK, Cherikh WS, Chambers DC, et al.. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant. 2018, 37:1155-1168. 10.1016\/j.healun.2018.07.022","journal-title":"J Heart Lung Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/02688697.2013.793288","article-title":"Muscle and nerve biopsy for the neurosurgical trainee","volume":"27","author":"Hart MG","year":"2013","unstructured":"Hart MG, Santarius T, Trivedi RA. Muscle and nerve biopsy for the neurosurgical trainee. Br J Neurosurg. 2013, 27:727-734. 10.3109\/02688697.2013.793288","journal-title":"Br J Neurosurg"},{"key":"ref11","article-title":"Mycophenolate mofetil induced myopathy in a patient with lupus nephritis","volume":"32","author":"Galindo M","year":"2005","unstructured":"Galindo M, Cabello A, Joven B, et al.. Mycophenolate mofetil induced myopathy in a patient with lupus nephritis. J Rheumatol. 2005, 32:188-190.","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2014.04.009","article-title":"Toxic myopathies","volume":"32","author":"Pasnoor M","year":"2014","unstructured":"Pasnoor M, Barohn RJ, Dimachkie MM. Toxic myopathies. Neurol Clin. 2014, 32:647-670. 10.1016\/j.ncl.2014.04.009","journal-title":"Neurol Clin"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-245. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42864-pregabalin-induced-myopathy-in-a-double-lung-transplant-recipient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:40Z","timestamp":1707506680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42864-pregabalin-induced-myopathy-in-a-double-lung-transplant-recipient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.11935","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,6]]}}}